Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users

NCT02070692 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Menstruation Disturbances

Interventions

DRUG: Tamoxifen
DRUG: Placebo

Sponsor

Oregon Health and Science University

Collaborators

[object Object]